Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01563094 · ClinicalTrials.gov registry record
Bone Accrual and Hormones in Response to Lactation
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 141
- Enrollment target
NCT01563094: Completed study, sponsored by University of Virginia.
NCT01563094 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 141 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01563094 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 141 participants
- Enrollment target
Study Summary
This is a prospective observational trial of healthy postpartum women to investigate changes in bone density and markers of bone turnover during lactation. The study hypothesis is that women who breast-feed 5 months or more will lose bone density and subsequently regain the bone density after weaning. This study seeks to define determinants of the regain in bone density.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2003-01 |
| Est. Completion | 2010-08 |
What the finished NCT01563094 record still lists
NCT01563094 is an observational study that tracks outcomes without assigning an intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01563094 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01563094 about?
NCT01563094 is a clinical study titled "Bone Accrual and Hormones in Response to Lactation". This is a prospective observational trial of healthy postpartum women to investigate changes in bone density and markers of bone turnover during lactation. The study hypothesis is that women who breast-feed 5 months or more will lose bone density and subsequently regain the bone density after weanin...
What is the current status of trial NCT01563094?
This trial is currently completed. The enrollment target is 141 participants. The study started on 2003-01. Estimated completion is 2010-08.
Who is sponsoring clinical trial NCT01563094?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia